GlassScriptPhysician profile
Laura Muller
NPI 1912526534
$3,578.25
in general payments reported to CMS, 2019-2025
19 companies · $2,023 in 2025
The $2,023 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $356 · 2024: $1,199 · 2025: $2,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,434 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,433.88 |
| Education | $144.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $947.18 | 2024-2025 | Impella |
| Inari Medical, INC. | $306.15 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cordis US Corp. | $299.31 | 2025 | Mynx Control Venous |
| Medtronic, INC. | $287.89 | 2025 | Azure Xt Dr Mri Surescan, Omniasecure Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $243.22 | 2025 | Lifevest |
| Pfizer INC. | $233.62 | 2023-2025 | |
| Cvrx, INC. | $179.45 | 2025 | Barostim Neo System |
| Abbott Laboratories | $166.67 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Alnylam Pharmaceuticals INC. | $145.60 | 2025 | Onpattro |
| Philips North America LLC | $143.36 | 2025 | Coronary Undivided |
| Scpharmaceuticals INC. | $139.80 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $135.12 | 2023-2024 | Inpefa |
| Boston Scientific Corporation | $96.87 | 2025 | General - Vascular Access |
| Astrazeneca Pharmaceuticals LP | $90.87 | 2024 | Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $51.72 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $40.06 | 2025 | |
| Bridgebio Pharma, INC. | $29.87 | 2025 | Attruby |
| Terumo Medical Corporation | $23.41 | 2024 | Metacross Otw, Tr Band |
| Harrow Eye, LLC | $18.08 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Muller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.